- Home
- ACCS vs HSCS Comparison
ACCS vs HSCS Comparison
Compare ACCS & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACCS | HSCS |
|---|---|---|
| Founded | 1988 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Publishing | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6M | 15.8M |
| IPO Year | 2014 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ACCS | HSCS |
|---|---|---|
| Price | $4.57 | $3.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.50 | N/A |
| AVG Volume (30 Days) | 5.5K | ★ 117.3K |
| Earning Date | 11-03-2026 | 09-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 139.36 | 50.84 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $22,619,000.00 | $4,319.00 |
| Revenue This Year | N/A | $295.93 |
| Revenue Next Year | $5.82 | $18,321.05 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.52 | $1.63 |
| 52 Week High | $11.34 | $5.25 |
Technical Indicators
Market Signals| Indicator | ACCS | HSCS |
|---|---|---|
| Relative Strength Index (RSI) | 40.15 | 44.34 |
| Support Level | $4.52 | $2.70 |
| Resistance Level | $4.99 | $3.72 |
| Average True Range (ATR) | 0.16 | 0.35 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 10.64 | 14.37 |
Price Performance
Historical ComparisonAbout ACCS ACCESS Newswire Inc.
ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.